Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

Mark Hallett, George Washington University
Alberto Albanese, Università Cattolica del Sacro Cuore, Milan, Italy
Dirk Dressler, Hannover Medical School, Hannover, Germany
Karen R. Segal
David M. Simpson, Mount Sinai Medical Center, New York NY
Daniel Truong, Parkinson and Movement Disorder Institute, Fountain Valley, CA
Joseph Jankovic, Baylor College of Medicine

pii: S0041-0101(12)00827-6. doi: 10.1016/j.toxicon.2012.12.004. [Epub ahead of print]

Abstract